Similar content being viewed by others Subjects Introduction Unimolecular dual agonists for the glucagon-like peptide 1 receptor (GLP1R) and glucagon receptor (GCGR) are emerging as a potential new class of therapeutics in type 2 diabetes (T2D) 1,2,3 and Non-Alcoholic Steato Hepatitis (NASH) 4,5,6
Found members get access to prescription medication (if they qualify), behavior change guidance, a supportive community, a team of health coaches, and an app to log healthy habits and track goals
Effect of Semaglutide on Coronary Atherosclerosis Progression in Patients With Type II Diabetes: Rationale and Design of the Semaglutide Treatment on Coronary Progression Trial
Order online from Woodmans
Lansard, M
Gastroenterology 142 , 355365.e351-354 (2012)